Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Fierce Pharma
McKesson acquires Maryland CRO for $2.25 billion
Healthcare conglomerate McKesson has dropped $2.25 billion for Precision Medicine Group's R&D and commercialization capabilities.
Donavyn Coffey
Aug 25, 2026 11:22am
Novartis pays $2B for breast cancer program as rivals circle
Mar 20, 2026 5:19am
Fierce Pharma
Servier rounds out rare cancer offerings with $2.5B Day One buy
Mar 6, 2026 10:14am
Asahi Kasei to buy Germany's Aicuris for $920M
Feb 26, 2026 2:00am
China is no longer licensing 'bargain basement': analyst
Feb 24, 2026 5:07pm
4 trends driving biopharma M&A this year, per Bain
Jan 28, 2026 5:00pm